4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000008
Chief Medical Officer sold 7,100 shares at $50.16 ($356,112)
- Chief Medical Officer acquired 7,100 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bowden Christopher · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-13 | Exercise or conversion : show line 1 in the form | +7,100 | $35.16 | $249,636 | 8,750 | D |
| 2020-02-13 | Sale : show line 2 in the form | −7,100 | $50.16 | $356,112 | 1,650 | D |
| Open-market sales · 7,100 sh · avg $50.16 · $356,112 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-13 | Exercise or conversion : show line 3 in the form Stock option (right to buy) | −7,100 | 19,306 | D |
Loading xslF345X03/wf-form4_158205991627413.xml…